-
1 Comment
Kobayashi Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 13.6% below its 200 day moving average.
From a valuation standpoint, the stock is 414.2% more expensive than other stocks from the Consumer Defensive sector with a price to sales ratio of 5.4.
Kobayashi Pharmaceutical Co., Ltd's total revenue sank by 9.5% to $45B since the same quarter in the previous year.
Its net income has increased by 1.4% to $4B since the same quarter in the previous year.
Based on the above factors, Kobayashi Pharmaceutical Co., Ltd gets an overall score of 1/5.
| ISIN | JP3301100008 |
|---|---|
| Exchange | TSE |
| CurrencyCode | JPY |
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Market Cap | 413B |
|---|---|
| Beta | 0.47 |
| PE Ratio | 40.64 |
| Target Price | 5725.7144 |
| Dividend Yield | 1.9% |
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese medicine; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air freshener, lens cleaner, cooling gel sheets, and oral hygiene products. It also manufactures and sells pharmaceuticals, cosmetics, and health foods; and manufactures and sells synthetic resin products; markets nutritional supplements and skin care products through mail orders; and sells skincare products, daily necessities, and health foods, as well as manufactures body warmers. In addition, the company engages in transportation, real estate management, and advertising planning and production businesses; manufacture of sanitary and paper products; and asset management. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 4967.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
